Patient-Derived Xenograft Model Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Tumor Type (Lung Cancer, Pancreatic Cancer, Prostate Cancer, Breast Cancer, Other Cancer), By Type (Mice, Rats), By End-User (Inpatient Settings, Community Settings) By Region and Competition
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationPatient-Derived Xenograft Model Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Tumor Type (Lung Cancer, Pancreatic Cancer, Prostate Cancer, Breast Cancer, Other Cancer), By Type (Mice, Rats), By End-User (Inpatient Settings, Community Settings) By Region and Competition
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 1.98 billion |
| CAGR (2023-2028) | 9.97% |
| Fastest Growing Segment | Breast Cancer |
| Largest Market | North America |
Market Overview
Key Market Drivers
Rising Cancer Incidence and Unmet Medical Needs
Advancements in PDX Technology
Biomarker Discovery and Drug Development
Key Market Challenges
Heterogeneity and Variability
Time and Resource Intensity
Costs and Accessibility
Key Market Trends
Rising Interest in Personalized Medicine
Advances in Genomic Profiling
Immunotherapy Revolution
Segmental Insights
Tumor Type Insights
Model Type Insights
Regional Insights
Recent Developments
- In December 2020, Collagen Matrix, Inc., a leader in collagen-based,regenerative, xenograft-derived medical devices, and Linden Capital Partners("Linden") announced the acquisition of Sunstar's DegradableSolutions . It includes the GUIDOR brand of synthetic, biodegradable medicalimplants. The goal of the acquisition is to increase the variety oftechnologies offered to clients.
- In April 2020, Crown Bioscience Inc. acquired unique models from LeadingAcademic Medical Centres and entered into partnerships with the University ofWashington and the Dana-Farber Cancer Institute. Both the company's productexpansion and the community working on oncology drugs benefit from this.
Key Market Players
- Charles River Laboratories Inc.
- TheJackson Laboratory
- CrownBioscience,Inc.
- AltogenLabs
- Envigo
- WuxiAppTec
- Oncodesign
- HeraBioLabs
- XenTech
- AbnovaCorporation
| By Tumor Type | By End User | By Type | By Region |
|
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy